Jeremy Sohn

Managing Partner at P74 Bio in October 2023 to Present

Member of the Board at NovaSignal in March 2016 to September 2022

Co-Head, Private Healthcare Ventures at Magnetar Capital in July 2021 to June 2022

Chairman, Investment Committee at dRx Capital in January 2018 to July 2021

VP, Global Head of Digital BD&L, Partnerships, & Innovation at Novartis in November 2015 to July 2021

Board Observer at COTA, Inc. in April 2016 to April 2021

Board Observer at Pear Therapeutics in March 2016 to April 2021

Board Observer at SchoolCare in June 2019 to April 2020

Global Head of Commercial Digital Medicines at Novartis in June 2017 to March 2018

Global Head of Digital Development at Novartis in February 2016 to December 2016

Board Observer at Clinical Ink in November 2015 to December 2016

Advisory Committee Member at SMART Platforms.org in January 2014 to December 2016

Chief Commercialization Officer at Clinical Ink in March 2015 to November 2015

Managing Director at MPM Capital in February 2013 to November 2015

President, CEO, & Founder at Florida Healthcare Analytics, Inc. (dba "CentrosHealth") in February 2013 to March 2015

President & Founder at TriNetX, Inc. in February 2013 to March 2015

Co-Founder, Executive Director at GrapeVine Group, LLC in March 2011 to December 2014

Chief Operating Officer (COO) at Measuring Success, LLC in May 2012 to January 2013

Chief Operating Officer at PanGenX in October 2011 to May 2012

COO and VP, Strategy & Corporate Development at North Plains Systems in January 2008 to September 2011

Private Equity Associate at Riverside Partners in October 2006 to December 2007

Co-Founder, CFO, and VP, Business & Corporate Development at Wasabi Systems Inc. in October 2000 to October 2006

Research Analyst at Shattuck Hammond Partners in January 1999 to January 2000

Analyst at The Lewin Group in January 1997 to January 1999